Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Rodriguez

Showing results (281-290 of 333) with videos related to

Pageof 34
Sort By:
Radiology|September 2, 1998
Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997M T Vlachaki, C S Ha, F B Hagemeister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Small noncleaved cell lymphoma in adults: superior results for stages I-III diseaseT M Lopez, F B Hagemeister, P McLaughlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
CHOP-Bleo plus interferon for stage IV low-grade lymphomaP McLaughlin, F Cabanillas, F B Hagemeister, et al.
Leukemia & Lymphoma|September 7, 2000
Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patientsJ E Romaguera, I F Khouri, H M Kantarjian, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|July 19, 2017
[Assessment of adherence to antibiotic treatment in Primary Care by determining levels of the drug using a liquid chromatography technique]P Navarro-Gómez, A Sorlózano-Puerto, M M Olmo-Navas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Paclitaxel (Taxol) for the treatment of lymphomaA Younes, J P Ayoub, A Sarris, et al.
Oncology (Williston Park, N.Y.)|August 11, 2001
Irinotecan in relapsed or refractory non-Hodgkin's lymphomaA H Sarris, J Romaguera, F B Hagemeister, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiationL M Fuller, M J Krasin, W S Velasquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapyA H Sarris, I Braunschweig, L J Medeiros, et al.
Blood|March 1, 1991
Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapyW S Velasquez, L M Fuller, S Jagannath, et al.
Pageof 34

Showing results (281-290 of 333) with videos related to

Sort By:
Pageof 34
Radiology|September 2, 1998
Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997M T Vlachaki, C S Ha, F B Hagemeister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1990
Small noncleaved cell lymphoma in adults: superior results for stages I-III diseaseT M Lopez, F B Hagemeister, P McLaughlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
CHOP-Bleo plus interferon for stage IV low-grade lymphomaP McLaughlin, F Cabanillas, F B Hagemeister, et al.
Leukemia & Lymphoma|September 7, 2000
Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patientsJ E Romaguera, I F Khouri, H M Kantarjian, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|July 19, 2017
[Assessment of adherence to antibiotic treatment in Primary Care by determining levels of the drug using a liquid chromatography technique]P Navarro-Gómez, A Sorlózano-Puerto, M M Olmo-Navas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Paclitaxel (Taxol) for the treatment of lymphomaA Younes, J P Ayoub, A Sarris, et al.
Oncology (Williston Park, N.Y.)|August 11, 2001
Irinotecan in relapsed or refractory non-Hodgkin's lymphomaA H Sarris, J Romaguera, F B Hagemeister, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiationL M Fuller, M J Krasin, W S Velasquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapyA H Sarris, I Braunschweig, L J Medeiros, et al.
Blood|March 1, 1991
Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapyW S Velasquez, L M Fuller, S Jagannath, et al.
Pageof 34